Rethinking Nike: Is the Iconic Brand Still a Buy Based on its Turnaround Story?

Nike expects Q4 fiscal 2026 revenue to fall as much as 4% year over year, with China revenue projected to decline about 20%. The article frames this as a turnaround story under CEO Elliott Hill, with North America identified as the key driver of recovery, but near-term softness in China and discount-driven inventory cleanup remain headwinds. The tone is cautious as investors wait for evidence that management can sustain momentum in the core U.S. business.

Analysis

The market is likely underestimating how much of this story is self-inflicted inventory normalization rather than pure demand destruction. That matters because a deliberate reset usually creates a cleaner earnings setup 2-3 quarters later: gross margin pain and revenue pressure now can translate into better full-price sell-through and less promotional leakage into the next holiday cycle. In that frame, the key variable is not the headline China decline, but whether North America wholesale can re-accelerate enough to offset the margin drag from clearing the old product mix.

The second-order effect is competitive. If Nike is pulling back on certain channels and assortments, share does not disappear evenly; it tends to migrate first to brands with fresher innovation and better retailer urgency, especially in running and performance categories. That creates a near-term relative advantage for smaller, more focused athletic names and for wholesale partners that can allocate shelf space to faster-turn product, while premium lifestyle exposure gets less benefit from the turnaround narrative.

From a timing standpoint, this is a months-long catalyst, not a days-long trade. The next inflection points will be channel checks, inventory days, and the company’s willingness to tolerate another quarter or two of “ugly but necessary” revenue comp to protect brand health. The contrarian risk is that investors may be too anchored to the China headline and miss that the real swing factor is whether North America demand can comp positive without deeper discounting; if it cannot, the turnaround gets pushed out another 2-4 quarters.

Key Decisions for Investors

• Stay tactical bearish on NKE into the next earnings window: sell a 1-2 quarter call spread or buy put spreads to express downside if North America fails to offset China, with defined risk and benefit from continued margin pressure.
• Relative-value pair: long a higher-growth athletic competitor / short NKE for the next 3-6 months, targeting share migration from weaker Nike assortments into fresher performance brands; best when wholesale checks show retailer shelf reallocation.
• If looking for a lower-risk expression, wait for a post-print pullback and then accumulate NKE only if North America revenue stabilizes and inventory growth decelerates for two consecutive quarters; reward improves when the market starts pricing in 2027 margin recovery.
• Avoid chasing the turnaround narrative before evidence of full-price sell-through emerges; the asymmetry is still to the downside until management proves the discounting cycle is ending.